Samsung Life Science invests in US biotech firm Latus Bio

Samsung Life Science Fund, managed by Samsung Group’s venture investment arm, has invested in US biotechnology firm Latus Bio Inc. during the ...

Samsung invests in BrickBio in US

Samsung Group announced on Tuesday that its Life Science Fund has invested in the US-based antibody-drug conjugates (ADC) and gene therapy technol...

Samsung targets gene therapy sector through US investments

Samsung Group is targeting the gene therapy business through investments in US biotechnology companies as the leading South Korean conglomerate is s...

ToolGen gets FDA approval for TGT-001 as ODD

South Korean genome editing developer ToolGen Inc. announced on Monday that its application for orphan drug designation (ODD) of the gene correction...

Dong-A ST, UMass to jointly research for gene therapy

South Korea's Dong-A ST announced on Friday it has signed a joint research agreement with the University of Massachusetts (UMass) Chan Medical Schoo...

SK becomes top shareholder of US contract drug maker CBM

SK Pharmteco Co., a South Korean contract development and manufacturing organization (CDMO), said on Wednesday it has secured management rights of t...

S.Korea's ToolGen develops gene-edited cow for artificial blood

South Korean genome editing developer ToolGen Inc. has teamed up with Lartbio Technology, a Seoul-based transgenic animal development company, to de...

Hyundai E&C to develop future residential model All Life-care House

South Korea's Hyundai Engineering & Construction (Hyundai E&C) has announced plans to create a future residential model, the All Life-care H...

LabGenomics, Amorepacific sign gene testing service supply deal

South Korea's molecular diagnostics company LabGenomics Co. announced on Monday that it has signed a gene testing service supply contract with Amore...

S.Korea's iNtRON launches halal test kit to target Middle Eastern market

South Korean biotech firm iNtRON Biotechnology Inc. is focusing on the Middle Eastern market with the introduction of its "LiliF Halal Real-time PCR...

Korea's ST Pharm completes new R&D hub for gene therapy

ST Pharm Co., a South Korean drug raw material-producing subsidiary of Dong-A Socio Holdings, said on Friday that it has finished building an R&...

Kolon signs MOU with Hanyang Univ. to develop gene therapy treatments

Kolon Industries Inc.'s Future Technology Institute said on Thursday that it had signed a memorandum of understanding with the Hanyang University In...

ToolGen, ANLBIO to jointly develop progeria treatments

South Korea's two biotech startups ToolGen Incorporated and ANLBIO on Tuesday signed a joint research and development agreement for developing proge...

Seegene's COVID-19 diagnostic product wins Product of the Year Award

Seegene Inc. said on Friday that its COVID-19 diagnostic product Allplex SARS-CoV-2 Assay received the Product of the Year Award at the BioSpectrum ...

Samsung Biologics in CDO deal talks with global pharma firm

FRANKFURT – Samsung Biologics Co., the world’s largest contract drugmaker, is in talks to develop medicines for a global pharmaceutical ...

K-bio firms embrace gene therapy CDMO as Samsung looks the other way

South Korea’s major biopharmaceutical companies are rapidly embracing the cell and gene therapy business under a contract drug-making mechanis...

Kolon Life inks technology transfer deal with Juniper Biologics

South Korea’s pharmaceutical company Kolon Life Science Inc. signed a technology export deal worth up to 723.4 billion won ($589.1 million) wi...

SK Bioscience seeks multi-billion-dollar M&As, eyes gene therapy sector

SK Bioscience Co., the biopharmaceutical unit of South Korea’s SK Group, is seeking multi-billion-dollar mergers and acquisitions to expand it...

Samsung’s Life Science Fund invests in US biotech Jaguar Gene Therapy

Samsung Group’s 150 billion won ($124 million) Life Science Fund launched last year has chosen a leading US gene therapy development company a...

SK Pharmteco to raise up to $498 mn on $5 bn valuation

SK Pharmteco, a contract development and manufacturing organization (CDMO) for pharmaceuticals, is slated to raise 400 billion ($332.2 million) to 6...

SK seeks to make Pfizer, Merck COVID-19 pills in CMO deals

SK Inc., the investment and holding company of South Korea’s SK Group, is seeking to make COVID-19 treatment pills developed by Pfizer Inc. an...

SK acquires 70% stake in Yposkesi to jump into cell, gene CMO business

SK Inc., the holding and investment company of SK Group, South Korea’s third-largest conglomerate, has acquired a 70% stake in Yposkesi, a Fre...

SK in talks to buy French biologics contract manufacturer

SK Holdings is in the early stages of negotiations to acquire France’s biologic contract manufacturing organization (CMO) Yposkesi, in a move ...